India logs 18,840 new COVID-19 cases in 24 hours; daily positivity rate stands at 4.14%

-

New Delhi: India reported 18,840 new COVID-19 cases and 43 patients deaths in the last 24 hours. The death toll in the country has gone up to 5,25,386, whereas active cases in the country now stand at 1,25,028, according to the Ministry of Health and Family Welfare.

As per the Health Ministry, 16,104 COVID-19 patients recovered from the disease in the last 24 hours, taking the total number of recoveries since the onset of the pandemic in the country to 4,29,53,980.

The daily positivity rate now stands at 4.14 per cent, while the rate of recovery currently is 98.51 per cent.

COVID-19 cases have been on a rise in West Bengal, where everyday more than 2000 cases are being reported.

According to the Times of India, a few private hospitals in Kolkata will admit only those COVID-19 patients whose oxygen saturation levels are low or have comorbidities, to keep wards and beds for non-COVID-19 patients.

The COVID-19 patients will be advised to stay in home isolation, and will only be admitted to the hospital if the condition worsens. This week, three COVID-19 deaths were reported from a private hospital, while the number of patients have increased, where the majority have mild symptoms, say hospitals.

Keeping in mind the rise of COVID-19 cases in the state, West Bengal Education Minister Bratya Basu on Friday said the state government is not immediately planning to close schools and colleges, and a decision on this will be taken on the advice of the Health Department.

Under the nationwide vaccination drive, 12,26,795 COVID-19 vaccines were administered in the last 24 hours. The cumulative vaccine doses jabbed to date are 1,98,65,36,288.

In the new phase of the universalization of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

According to the Indian Express, Corbevax and Covaxin were approved for children aged between five and 12 years, by the NTAGI’s Standing Technical Sub-Committee (STSC).

There was no decision made to introduce these vaccines in the current vaccination drive. Members of the STSC discussed data concerning Corbevax from Biological E and Covaxin from Bharat Biotech, and decided to recommend the vaccines for children between the ages of five and 12 years.

With inputs from agencies

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.



from Firstpost India Latest News https://ift.tt/InapHu2
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

120 flights delayed, 30 trains running late; Delhi fog & cold wave continue to give shiver to travellers

-
Arrival and departure of 120 flights, both domestic and international, to Delhi airport were affected due to dense fog and cold wave conditions on Wednesday, according to Delhi Airport FIDS (Flight Information Display System). As per the Delhi Airport FIDS, a total of 53 flights, including 21 domestic arrivals, 16 domestic departures, 13 international departures and three international arrivals scheduled are cancelled and not operating due to fog and other operational reasons from and to Indira Gandhi International (IGI) Airport in the national capital on 17 January. #WATCH | Delhi: Several flight operations delayed at IGI airport due to low visibility amid fog. pic.twitter.com/hG1DUKllEt — ANI (@ANI) January 17, 2024 Visuals from the Delhi airport showed passengers waiting outside, checking update of their scheduled flights. There were also some people waiting for flight of their families, friends and loved ones to arrive, which got delayed due to fog. #WATCH | Delhi | Pas
Read more